Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Idec commences clinical trials with PRIMATIZED anti-B7 antibody in psoriasis

Oct. 27, 1998

Tacalcitol lotion equivalent to ointment in animal study

Oct. 23, 1998

Fexofenadine in the treatment of chronic idiopathic urticaria

Oct. 22, 1998

Tacrolimus in the long-term treatment of atopic dermatitis

Oct. 22, 1998

Optimal dosing regimen defined for OCT in dose-finding studies

Oct. 21, 1998

Photoprotective efficacy obtained with topical application of vitamin C

Oct. 21, 1998

Linoladiol cream: a novel approach to treating acne

Oct. 21, 1998

Overview of studies on SDZ-ASM-981, a potential new gold standard in treating atopic dermatitis

Oct. 21, 1998

Licensing opportunity from BTG: 12(R)-HETE formation inhibitor for psoriasis

Oct. 21, 1998

Licensing opportunity from BTG: topically active 5-LO inhibitor for psoriasis

Oct. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.